These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35200409)

  • 1. Design and Evaluation of Engineered Extracellular Vesicle (EV)-Based Targeting for EGFR-Overexpressing Tumor Cells Using Monobody Display.
    Komuro H; Aminova S; Lauro K; Woldring D; Harada M
    Bioengineering (Basel); 2022 Jan; 9(2):. PubMed ID: 35200409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach.
    Kooijmans SAA; Gitz-Francois JJJM; Schiffelers RM; Vader P
    Nanoscale; 2018 Feb; 10(5):2413-2426. PubMed ID: 29334397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dual-Reporter Platform for Screening Tumor-Targeted Extracellular Vesicles.
    Kanada M; Linenfelser L; Cox E; Gilad AA
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display.
    Antes TJ; Middleton RC; Luther KM; Ijichi T; Peck KA; Liu WJ; Valle J; Echavez AK; Marbán E
    J Nanobiotechnology; 2018 Aug; 16(1):61. PubMed ID: 30165851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Extracellular Vesicles to Target Pancreatic Tissue
    Komuro H; Kawai-Harada Y; Aminova S; Pascual N; Malik A; Contag CH; Harada M
    Nanotheranostics; 2021; 5(4):378-390. PubMed ID: 33912378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting.
    Kooijmans SA; Aleza CG; Roffler SR; van Solinge WW; Vader P; Schiffelers RM
    J Extracell Vesicles; 2016; 5():31053. PubMed ID: 26979463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery.
    Ivanova A; Badertscher L; O'Driscoll G; Bergman J; Gordon E; Gunnarsson A; Johansson C; Munson MJ; Spinelli C; Torstensson S; Vilén L; Voirel A; Wiseman J; Rak J; Dekker N; Lázaro-Ibáñez E
    Adv Sci (Weinh); 2023 Dec; 10(34):e2304389. PubMed ID: 37867228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
    Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
    J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia.
    Tian T; Cao L; He C; Ye Q; Liang R; You W; Zhang H; Wu J; Ye J; Tannous BA; Gao J
    Theranostics; 2021; 11(13):6507-6521. PubMed ID: 33995671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HaloTag display enables quantitative single-particle characterization and functionalization of engineered extracellular vesicles.
    Mitrut RE; Stranford DM; DiBiase BN; Chan JM; Bailey MD; Luo M; Harper CS; Meade TJ; Wang M; Leonard JN
    bioRxiv; 2024 May; ():. PubMed ID: 37808729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HaloTag display enables quantitative single-particle characterisation and functionalisation of engineered extracellular vesicles.
    Mitrut RE; Stranford DM; DiBiase BN; Chan JM; Bailey MD; Luo M; Harper CS; Meade TJ; Wang M; Leonard JN
    J Extracell Vesicles; 2024 Jul; 13(7):e12469. PubMed ID: 38965984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational and biophysical robustness in a prestabilized monobody.
    Chandler PG; Tan LL; Porebski BT; Green JS; Riley BT; Broendum SS; Hoke DE; Falconer RJ; Munro TP; Buckle M; Jackson CJ; Buckle AM
    J Biol Chem; 2021; 296():100447. PubMed ID: 33617878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Phage Display and Other Molecular Display Methods for the Development of Monobodies.
    Koide A; Koide S
    Cold Spring Harb Protoc; 2024 May; 2024(5):107982. PubMed ID: 37137569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
    Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
    Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the pharmacokinetics, biodistribution and plasma stability of monobodies.
    Dinh-Fricke AV; Hantschel O
    Front Pharmacol; 2024 Apr; 15():. PubMed ID: 38617793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering Calreticulin-Targeting Monobodies to Detect Immunogenic Cell Death in Cancer Chemotherapy.
    Zhang Y; Thangam R; You SH; Sultonova RD; Venu A; Min JJ; Hong Y
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic characterization of extracellular vesicle sorting domains and quantification at the single molecule - single vesicle level by fluorescence correlation spectroscopy and single particle imaging.
    Corso G; Heusermann W; Trojer D; Görgens A; Steib E; Voshol J; Graff A; Genoud C; Lee Y; Hean J; Nordin JZ; Wiklander OPB; El Andaloussi S; Meisner-Kober N
    J Extracell Vesicles; 2019; 8(1):1663043. PubMed ID: 31579435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin type III domain based monobody with high avidity.
    Duan J; Wu J; Valencia CA; Liu R
    Biochemistry; 2007 Nov; 46(44):12656-64. PubMed ID: 17929945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of Extracellular Vesicle Subpopulations Via Affinity Chromatography.
    Hung ME; Lenzini SB; Stranford DM; Leonard JN
    Methods Mol Biol; 2018; 1740():109-124. PubMed ID: 29388139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Differentiation in Monobodies Based on the Fibronectin Type 3 Domain.
    Chandler PG; Buckle AM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.